What You Should Know:
- GHX, a healthcare supply chain leader announced it has entered into a definitive agreement to receive a strategic investment from private equity firm Warburg Pincus. As part of this transaction, minority investor Thoma Bravo has exited its investment. Existing investor Temasek, an investment company headquartered in Singapore, will remain the majority equity holder.
- GHX has employees in the United States, Canada and Europe and is known for operating the largest
Read More
Healthcare Private Equity | PE | M&A| News, Analysis, Insights
PE Firm Frazier Healthcare Partners Closes $1.4B Growth Buyout Fund
What You Should Know:
- Frazier Healthcare Partners, a Seattle-based healthcare private equity firm announced the close of its tenth global buyouts fund and 13th fund across buyouts and life sciences. Investment focus will continue to be middle market provider-based businesses, with virtual health as a major component. The oversubscribed $1.4 billion fund, FHGB X, is significantly larger than FHGB IX, which closed at $780M in 2018.
- Frazier, 30 years strong this year,
Read More
PE Firm Thoma Bravo Acquires Clinical Trial Financial Platform Greenphire – Health M&A
What You Should Know:
- Thoma Bravo, a private equity investment firm focused on the software and technology-enabled services sector announced that it has reached an agreement to acquire Greenphire, a financial lifecycle management software for clinical trials, from The Riverside Company. Financial details were not disclosed for the pending transaction.
- The acquisition, which is subject to customary regulatory approvals, is expected to close in the second quarter of this year.
-
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies.
By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds
What You Should Know:
Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III.
The three new funds include a broad range of medical institutions, university endowments, foundations, pension funds and sovereign wealth funds.
- OrbiMed Private Investments
Read More
Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization
What You Should Know:
- Private equity firm Advent International announced that
it has completed a recapitalization of RxBenefits, the employee benefits
industry’s first and only technology-enabled pharmacy benefits optimizer (PBO).
- The transaction values RxBenefits at approximately $1.1
billion.
Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced that it has completed a recapitalization of RxBenefits, the
Read More
Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund
What You Should Know:
- Healthcare private equity firm Heritage Group launches a $300M fund to invest in high-growth healthcare services and technology companies.
- Heritage is backed by some of the leading healthcare organizations in the nation, including large provider systems, payers, and healthcare service providers.
Heritage Group, a Nashville, TN-based healthcare-focused private equity firm, today announced the closing of over $300 million in its oversubscribed third fund, an
Read More
2020’s Top 20 Digital Health M&A Deals Totaled $50B
Teladoc Health and Livongo Merge
The combination of Teladoc Health and Livongo creates a
global leader in consumer-centered virtual care. The combined company is
positioned to execute quantified opportunities to drive revenue synergies of
$100 million by the end of the second year following the close, reaching $500
million on a run-rate basis by 2025.
Price: $18.5B in value based on each share of Livongo
will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration
of
Read More
Israeli Digital Health VC Firm OTV Closes $170M Venture Fund
What You Should Know:
- OTV (formerly Olive Tree
Ventures), Israel’s ‘digital health first’ venture capital firm closes $170
million venture fund to support innovative digital health companies worldwide.
- OTV also announced today a new China
office and the appointment of Jose Antonio Urrutia Rivas as Head of Asia
Pacific.
OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of
Read More
M&A: CarepathRx Acquires Pharmacy Operations of Chartwell from UPMC for $400M
What You Should Know:
- CarepathRx will
acquire the University of Pittsburgh Medical Center’s pharmacy operations in a
$400M deal.
- The company fully
integrates pharmacy operations, expands healthcare services, improves
ambulatory access, minimizes clinical variation and creates new health system
revenue streams.
- CarepathRx serves more than 15 health systems and 600
hospitals, with more than 1,500 employees nationwide, 400 payor contracts.
Already CarepathRx has treated more than
Read More
